New questionnaire to measure symptoms in people with cardiac dysautonomia
Tests a new symptom questionnaire in adults with cardiac dysautonomia.
Key facts
- Who runs it
- Kansas City Heart Rhythm Research Foundation
- Where
- Overland Park, United StatesSee the 3 sites
- Trial code
- Registry title
- Development and Validation of the Kansas City Cardiac Dysautonomia Questionnaire (KCDysQ)
- Status
- Not yet recruiting
- People taking part
- 100 people, planned
- Started
- Jan 2026
- Planned end
- Aug 2026
- Type of study
- Interventional, 2 groups
- Treatments tested
- Kansas City Cardiac Dysautonomia Questionnaire (KCDysQ)
- Record updated
- 28 August 2025
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with POTS, IST (a fast heart rate at rest without a clear cause) or vasovagal syncope (fainting). They will fill in a new questionnaire about how the condition affects daily life.
- Age
- 18 Years and older
- Sex
- All
- Disease stage
- Diagnosis of POTS, IST or vasovagal syncope. People can be newly diagnosed or untreated, or already diagnosed and treated, including after sinus node modification.
Main reasons for not taking part
- Severe heart failure (NYHA Class III or IV)
- Severe COPD (GOLD 3 or 4, Group C or D)
- Current cancer not in remission
- Autoimmune disease needing long-term steroids or immune-changing drugs, such as rheumatoid arthritis, lupus, sarcoidosis or psoriasis
- Kidney failure needing haemodialysis, cirrhosis of the liver, or an organ or bone marrow transplant needing immune-suppressing drugs
The registry criteria, word for word
Show all 6 criteriaShow less
Who can take part
- Patients with a Diagnosis of POTS, IST, or vasovagal syncope
Who cannot take part
- Patients with comorbid chronic conditions causing significant impairments in quality of life, defined as:
- NYHA Class III or IV Heart Failure
- Any patients with current malignancy not in remission
- Any patient with history of Autoimmune disease requiring chronic steroid therapy or immunomodulatory agents: Rheumatoid Arthritis, Lupus, Sarcoidosis, Psoriasis All patients with ESRD requiring hemodialysis All patients with cirrhosis of any origin Any patients with solid organ or bone marrow transplant requiring immunosuppressive therapy
- COPD GOLD 3 or 4, Group C or D
Where in United States
- Kansas City Heart Rhythm InstituteOverland Park, United StatesContact: Donita AtkinsNot yet recruiting
- Midwest Heart and Vascular SpecialistsOverland Park, United StatesContact: Donita AtkinsNot yet recruiting
- Overland Park Regional Medical CenterOverland Park, United StatesContact: Donita AtkinsNot yet recruiting
About the trial
What the trial wants to find out
Main aim will be to compare in patients with cardiac dysautonomia, newly developed disease specific questionnaire to established generalized SF-36 and EQ-5d questionnaires, as there are no disease specific questionnaires for comparison. These novel and established questionnaires will then be compared among groups who have relatively stable disease or stable symptoms with patients who will be expected to have a change in symptoms and QoL.
The 2 groups in the trial
- Newly diagnosed/untreated/incompletely treated for Cardiac Dysautonomia PatientsOther group
Newly diagnosed/untreated/incompletely treated for Cardiac Dysautonomia (Postural Orthostatic Tachycardia Syndrome (POTS), Inappropriate Sinus Tachycardia (IST), and Vasovagal syncope (VVS)) Patients
Treatment: Kansas City Cardiac Dysautonomia Questionnaire (KCDysQ)
- Previously diagnosed/treated/undergone sinus node modification for Cardiac Dysautonomia PatientsOther group
Previously diagnosed/treated/previously undergone sinus node modification for Cardiac Dysautonomia Patients (Postural Orthostatic Tachycardia Syndrome (POTS), Inappropriate Sinus Tachycardia (IST), and Vasovagal syncope (VVS)) Patients
Treatment: Kansas City Cardiac Dysautonomia Questionnaire (KCDysQ)
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Development and Validation of the Kansas City Cardiac Dysautonomia Questionnaire (KCDysQ) in Patients With Postural Orthostatic Tachycardia Syndrome, Inappropriate Sinus Tachycardia, and Other Disorders of Cardiac Dysautonomia
- Plain-language title
- New questionnaire to measure symptoms in people with cardiac dysautonomiaGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 14 November 2026.
- Record updated
- 28 August 2025